Potentially
dilutive securities, on a weighted average basis, that were not included in the calculation of diluted net loss per share attributable
to common stockholders for the three and six months ended December 31, 2025 and six months ended December 31, 2024 because their effect
would be anti-dilutive are as follows (in common equivalent shares):
SCHEDULE
OF ANTI_DILUTIVE POTENTIALLY DILUTIVE SECURITIES
| | |
2025 | | |
2024 | | |
2025 | | |
2024 | |
| | |
For the Three Months Ended | | |
For the Six Months Ended | |
| | |
December 31, | | |
December 31, | |
| | |
2025 | | |
2024 | | |
2025 | | |
2024 | |
| Options | |
| 4,806,112 | | |
| 5,262,985 | | |
| 4,780,014 | | |
| 5,384,079 | |
| Warrants | |
| 737,500 | | |
| 897,717 | | |
| 737,500 | | |
| 867,609 | |
| Total | |
| 5,543,612 | | |
| 6,160,702 | | |
| 5,517,514 | | |
| 6,251,688 | |
|